英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:

regulus    
n. 狮子座的一等星,熔渣

狮子座的一等星,熔渣

Regulus
n 1: the brightest star in Leo
2: a genus of birds of the family Sylviidae including kinglets
[synonym: {Regulus}, {genus Regulus}]

Regulus \Reg"u*lus\ (-l?s), n.; pl. E. {Reguluses} (-?z), L.
{Reguli} (-l?). [L., a petty king, prince, dim. of rex,
regis, a king: cf. F. r['e]gule. See {Regal}.]
1. A petty king; a ruler of little power or consequence.
[1913 Webster]

2. (Chem. & Metal.) The button, globule, or mass of metal, in
a more or less impure state, which forms in the bottom of
the crucible in smelting and reduction of ores.
[1913 Webster]

Note: The name was introduced by the alchemists, and applied
by them in the first instance to antimony. It signifies
little king; and from the facility with which antimony
alloyed with gold, these empirical philosophers had
great hopes that this metal, antimony, would lead them
to the discovery of the philosopher's stone. --Ure.
[1913 Webster]

3. (Astron.) A star of the first magnitude in the
constellation Leo; -- called also the {Lion's Heart}.
[1913 Webster]


请选择你想看的字典辞典:
单词字典翻译
regulus查看 regulus 在百度字典中的解释百度英翻中〔查看〕
regulus查看 regulus 在Google字典中的解释Google英翻中〔查看〕
regulus查看 regulus 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Regulus - Wikipedia
    Regulus is the brightest object in the constellation Leo and one of the brightest stars in the night sky It has the Bayer designation designated α Leonis, which is Latinized to Alpha Leonis, and abbreviated Alpha Leo or α Leo
  • Regulus Therapeutics Enters into Agreement to be Acquired by Novartis . . .
    Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a pipeline complemented by a rich intellectual property estate in the microRNA field Regulus maintains its corporate headquarters in San Diego, CA
  • Regulus Therapeutics
    We are laser-focused on our mission: to improve the lives of patients and their families Our pipeline programs target kidney diseases of high unmet need, including ADPKD We are targeting the underlying biology of these diseases with a novel and potentially powerful approach: MicroRNA-based therapeutics News
  • Novartis announces commencement of tender offer to acquire Regulus . . .
    Basel, May 27, 2025 - Novartis today announced that Redwood Merger Sub Inc , a Delaware corporation and an indirect wholly owned subsidiary of Novartis (“Purchaser”), has commenced a tender offer to acquire all of the outstanding shares of common stock, par value $0 001 per share (the “Shares”), of Regulus Therapeutics Inc , a Delaware corporation (“Regulus”), in exchange for (i
  • Novartis pays $800M to buy Regulus for phase 3-ready kidney drug
    Novartis has committed another $1 7 billion to its ambition to become a kidney disease leader The Swiss drugmaker is making the outlay, around half of which is upfront, to buy Regulus
  • Novartis grabs kidney drug developer Regulus in $1. 7bn deal
    Novartis has reached an agreement to buy Regulus Therapeutics and its experimental therapy for autosomal dominant polycystic kidney disease (ADPKD) for $800 million upfront in a deal that could
  • Novartis to acquire Regulus in deal for kidney disease drug
    Novartis will pay $800 million upfront to acquire Regulus Therapeutics, a San Diego biotechnology company that launched nearly two decades ago with plans to make drugs capable of targeting small
  • Don’t Miss The Rare Mars-Regulus ‘Kiss’ This Week As Red Meets Blue
    The red planet Mars will be next to bright blue star Regulus this coming week, creating a rare contrast in colors in the night sky The key night is Monday, June 16
  • Novartis to acquire Regulus Therapeutics and farabursen, an - GlobeNewswire
    Basel, April 30, 2025 – Novartis today announced that it has entered into an agreement to acquire Regulus Therapeutics, a San Diego-based, publicly traded (Nasdaq: RGLS) clinical-stage
  • Regulus Therapeutics (NASDAQ:RGLS) Stock Price Crosses Above Two . . .
    Regulus Therapeutics (NASDAQ:RGLS - Get Free Report) last released its earnings results on Thursday, May 8th The biopharmaceutical company reported ($0 15) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0 29) by $0 14 On average, research analysts predict that Regulus Therapeutics Inc will post -0 88





中文字典-英文字典  2005-2009